97353 ⎘
Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
Metal-Binding Bacterial Protein Fibers
#2CLEC9A BINDING AGENTS
#3SELF-ASSEMBLING PEPTIDE GEL FORMULATION AND METHODS OF USE
#4KARI Nanoparticle
#5CD8 BINDING AGENTS
#6PSEUDO-VIRAL PARTICLES AND USES OF SAME
#7PREFUSION RSV F PROTEINS AND THEIR USE
#8PROTEIN DOUBLE-SHELL NANOSTRUCTURES AND THEIR USE
#9PREFUSION RSV F PROTEINS AND THEIR USE
#10LENTIVIRAL-BASED VECTORS AND RELATED SYSTEMS AND METHODS FOR EUKARYOTIC GENE EDITING
#11EXPRESSION AND SECRETION SYSTEM
#12RSV F Protein Mutants
#13Polypeptide Assemblies and Methods for the Production Thereof
#14PATHOGEN-LIKE ANTIGEN-BASED VACCINE AND PREPARATION METHOD THEREFOR
#15A PEPTIDE AND THE SELECTION METHOD THEREOF
#16MOLECULAR INDEXING OF PROTEINS BY SELF ASSEMBLY (MIPSA) FOR EFFICIENT PROTEOMIC INVESTIGATIONS
#17POLYPEPTIDES TARGETING SARS-COV-2 AND RELATED COMPOSITIONS AND METHODS
#18Self-assembling protein nanostructures displaying paramyxovirus and/or pneumovirus F proteins and their use
#19CLASS 2 TYPE V CRISPR-CAS PRIME EDITING
#20Modified Butyrophilin and Butyrophilin Complexes
#21NANOSTRUCTURE-FORMING POLYPEPTIDES AND USES THEREOF
#22SELF-ASSEMBLING PROTEIN NANOPARTICLES WITH BUILT-IN SIX-HELIX BUNDLE PROTEINS
#23VACCINE COMPOSITIONS AND THEIR USE
#24NANOPARTICLE PLATFORM FOR ANTIBODY AND VACCINE DELIVERY
#25ENGINEERED MCP AND PCP PROTEINS AND SYSTEMS AND METHODS THEREOF
#26PRE-FUSION RSV F ANTIGENS
#27IMMUNOGENIC COMPOSITIONS AND THEIR USES
#28RNA EXPORT FOR MEASUREMENT AND MANIPULATION OF CELLS
#29MODIFIED MULTABODY CONSTRUCTS, COMPOSITIONS, AND METHODS TARGETING SARS-COV-2
#30SARS-COV-2 SPIKE FUSED TO A HEPATITIS B SURFACE ANTIGEN
#31EPSTEIN-BARR VIRUS VACCINES
#32FUSION PROTEINS OF NATURAL HUMAN PROTEIN FRAGMENTS TO CREATE ORDERLY MULTIMERIZED IMMUNOGLOBULIN Fc COMPOSITIONS
#33NOVEL PROTEIN HAVING METHANE OXIDATION ACTIVITY
#34MODULAR RECONFIGURABLE ASYMMETRIC PROTEIN ASSEMBLIES
#35OLIGOMERIZATION PARTICLE FORMATION FUSION PROTEIN WITH IMMUNOGENIC ANTIGEN
#36Method for Manufacturing Biosensor
#37HUMAN PAPILLOMAVIRUS TYPE 18 CHIMERIC PROTEIN AND USE THEREOF
#38SELF-ASSEMBLING INSECT FERRITIN NANOPARTICLES
#39PRE-FUSION RSV F ANTIGENS
#40PREFUSION-STABILIZED LASSA VIRUS GLYCOPROTEIN COMPLEX AND ITS USE
#41Prefusion RSV F proteins and their use
#42POLYPEPTIDES TARGETING DR4 AND/OR DR5 AND RELATED COMPOSITIONS AND METHODS
#43NUCLEIC ACID MOLECULES ENCODING TRIF AND ADDITIONAL POLYPEPTIDES AND THEIR USE IN TREATING CANCER
#44COMPOSITIONS AND METHODS FOR DOMINANT ANTIVIRAL THERAPY
#45Self-assembling protein nanostructures displaying paramyxovirus and/or pneumovirus F proteins and their use
#46PROTEIN-BASED MATERIAL FOR BIOCATALYSIS
#47EXPRESSION AND SECRETION SYSTEM
#48Glycoengineered protein nanoparticles and uses thereof
#49Prefusion RSV F proteins and their use
#50COMPOSITIONS AND METHODS USING METHANOTROPHIC S-LAYER PROTEINS FOR EXPRESSION OF HETEROLOGOUS PROTEINS
#51ANTIBODY-LIKE PROTEIN AND USE THEREOF
#52MULTIMERIC PROTEIN COMPLEXES AS ANTIBODY SUBSTITUTES FOR NEUTRALIZATION OF VIRAL PATHOGENS IN PROPHYLACTIC AND THERAPEUTIC APPLICATIONS
#53SELF-ASSEMBLING URICASE FUSION PEPTIDES
#54PROTEIN DOUBLE-SHELL NANOSTRUCTURES AND THEIR USE
#55HETEROLOGOUS PROTEINS WITH AXONEMAL PROTEINS
#56Polypeptide Assemblies and Methods for the Production Thereof
#57MODULAR PLATFORM FOR PROGRAMMABLE SPATIOTEMPORAL BIOMOLECULE CLUSTERING WITH APPLICATIONS INCLUDING ENHANCED METABOLIC YIELD
#58COMPOSITIONS AND METHODS FOR ENZYME IMMOBILIZATION
#59INTRACELLULAR MOLECULAR RECORDING AND MEMORY VIA PROTEIN SELF-ASSEMBLY
#60RSV F Protein Mutants
#61BINDING MOLECULES WITH MODIFIED J-CHAIN
#62RAPID AND FACILE ANTIBODY DETECTION USING COVALENTLY IMMOBILIZED SELF-ASSEMBLED POLYPEPTIDES
#63MULTIMERS, TETRAMERS & OCTAMERS
#64ADHESIVE ELASTIN AND SUCKERIN-BASED MULTIBLOCK COPOLYPEPTIDE WITH STIMULUS RESPONSIVENESS AND SURFACE ADHESION, SELF-ASSEMBLED STRUCTURE THEREOF, AND APPLICATION OF INJECTABLE HYDROGEL AS BIOADHESIVE
#65METHOD FOR PREPARING IMMOBILIZED ARGININE DEIMINASE (ADI) AND PRODUCING [14/15N]-L-CITRULLINE
#66Multifunctional Heteromultimeric Constructs
#67MEANS AND METHODS FOR PREPARING ENGINEERED TARGET PROTEINS BY GENETIC CODE EXPANSION IN A TARGET PROTEIN-SELECTIVE MANNER
#68VIRUS-LIKE PARTICLE WITH EFFICIENT EPITOPE DISPLAY
#69EXPORTED RNA REPORTERS FOR LIVE-CELL MEASUREMENT
#70POPTAG PEPTIDE AND USES THEREOF
#71COMPOSITIONS AND METHODS FOR DELIVERING CARGO TO A TARGET CELL
#72CHIMERIC GAS VESICLE AND PROTEIN EXPRESSION SYSTEM THEREFOR
#73CLEC9A BINDING AGENTS
#74Pre-fusion RSV F antigens
#75Self-Assembling Protein Nanostructures Displaying Paramyxovirus and/or Pneumovirus F Proteins and Their Use
#76Compositions and methods related to ebolavirus vaccines
#77INFLUENZA HEMAGGLUTININ PROTEINS AND METHODS OF USE THEREOF
#78SINGLE CHAIN FUSIONCONSTRUCTS COMPRISING MULTIMERIC ANTIBODY FRAGMENTS FUSED TO COLLAGEN TRIMERIZATION DOMAINS
#79Self-assembled protein nanoparticle and its applications thereof
#80CD8 BINDING AGENTS
#81Self-assembling protein nanostructures displaying paramyxovirus and/or pneumovirus F proteins and their use
#82RESPIRATORY SYNCYTIAL VIRUS RECOMBINANT F PROTEIN AND VACCINE COMPOSITION CONTAINING SAME
#83Prefusion RSV F proteins and their use
#84Fusion proteins of natural human protein fragments to create orderly multimerized immunoglobulin Fc compositions
#85Anti-inflammatory nanofibers
#86Compositions and methods related to ebolavirus vaccines
#87EMULSOMES COMPRISING S-LAYER FUSION PROTEINS AND METHODS OF USE THEREOF
#88STABILIZED PRE-FUSION RSV F PROTEINS
#89Designer Peptide Opsonins
#90Polypeptide Assemblies and Methods for the Production Thereof
#91DISORDERED PROTEIN-BASED SEEDS FOR MOLECULAR CLUSTERING
#92Light-inducible protein aggregation system for modeling proteinopathies and neurodegenerative disorders
#93Coronaviruses epitope-based vaccines
#94SELF-ASSEMBLING PEPTIDE GEL FORMULATION AND METHODS OF USE
#95Self-assembling insect ferritin nanoparticles
#96VISTA-Ig constructs and the use of VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
#97Self-assembling peptide for activating human mast cells
#98PEPTIDES, ESPECIALLY POLYPEPTIDES, PHAGE DISPLAY SCREENING METHOD AND ASSOCIATED MEANS, AND THEIR USES FOR RESEARCH AND BIOMEDICAL APPLICATIONS
#99Co-assembly peptides, nanostructures, and methods of making and using the same
#100Methods for simultaneous measurement of multiple biological signals from spectrally identical fluorescent reporters
#101Compositions and methods using methanotrophic S-layer proteins for expression of heterologous proteins
#102LENTIVIRAL-BASED VECTORS AND RELATED SYSTEMS AND METHODS FOR EUKARYOTIC GENE EDITING
#103Self-assembling protein nanostructures displaying paramyxovirus and/or pneumovirus F proteins and their use
#104EXPRESSION AND SECRETION SYSTEM
#105Epstein-barr virus vaccines
#106GENETICALLY ENCODED FLUORESCENT-IRON FERRITIN NANOPARTICLE PROBES FOR DETECTING AN INTRACELLULAR TARGET BY FLUORESCENT AND ELECTRON MICROSCOPY
#107CORONAVIRUSES EPITOPE-BASED VACCINES
#108Virus-like particle (VLP) based small molecule-protein interaction trap
#109Binding molecules with modified J-chain
#110Genetic reprogramming of bacterial biofilms
#111THERAPEUTIC CANCER VACCINE TARGETED TO HAAH (ASPARTYL-[ASPARAGINYL]-BETA-HYDROXYLASE)
#112Compositions and methods for transient delivery of nucleases
#113Polypeptide assemblies and methods for the production thereof
#114Nanonets and spherical particles
#115Non-immunogenic protein nanoparticles with cancer targeting activity using albumin-binding peptide
#116Nanoparticle platform for antibody and vaccine delivery
#117GITRL FUSION PROTEINS AND USES THEREOF
#118Compositions and methods for enzyme immobilization
#119Virus-like particle with efficient epitope display
#120Engineered shell proteins for microcompartment shell electron transfer and catalysis
#121Disordered protein-based seeds for molecular clustering
#122CD20 scFv-ELPs methods and therapeutics
#123Particle for the encapsidation of a genome engineering system
#124Method for detecting protein-protein interactions in a cell utilizing particle-forming polypeptide-bait fusion proteins and virus-like particles
#125SELF-ASSEMBLING PROTEIN NANOPARTICLES WITH BUILT-IN SIX-HELIX BUNDLE PROTEINS
#126Multifunctional heteromultimeric constructs
#127Bispecific signaling agents and uses thereof
#128Virus-like particle (VLP) based small molecule-protein interaction trap
#129Clec9A binding agents
#130Phage conjugates and uses thereof
#131Self-assembling insect ferritin nanoparticles for display of co-assembled trimeric antigens
#132Genetically encoded lipid-polypeptide hybrid biomaterials that exhibit temperature triggered hierarchical self-assembly
#133Method for increasing the secretion levels of interleukin 2 and muteins thereof by introducing a point mutation
#134Anti-inflammatory nanofibers
#135NEGATIVE SELECTION AND STRINGENCY MODULATION IN CONTINUOUS EVOLUTION SYSTEMS
#136Multimers, tetramers and octamers
#137Adjuvants
#138Viral particle for the transfer of RNAs, especially into cells involved in immune response
#139Binding molecules with modified J-chain
#140Methods and compositions for protein delivery
#141RSV F protein mutants
#142Substitutions-modified prefusion RSV F proteins and their use
#143HIV peptide vaults and methods of making and using thereof
#144CD8 binding agents
#145Single chain fusionconstructs comprising multimeric antibody fragments fused to collagen trimerization domains
#146Virus-like particle with efficient epitope display
#147Method for fabricating two-dimensional protein crystals
#148Electrically conductive protein nanofibers and biofilms
#149Coronaviruses epitope-based vaccines
#150Prefusion RSV F proteins and their use
#151Heat-inducible self-assembling protein domains
#152Binding molecules with modified J-chain
#153IL-33 antagonists and uses thereof
#154EpCAM targeted polypeptides, conjugates thereof, and methods of use thereof
#155Influenza hemagglutinin proteins and methods of use thereof
#156PRE-FUSION RSV F ANTIGENS
#157Engineered shell proteins for microcompartment shell electron transfer and catalysis
#158Genetic reprogramming of bacterial biofilms
#159METHOD FOR CELL ENERGY THERAPEUTICS
#160METHODS AND COMPOSITIONS FOR TREATING HIV
#161Compositions and methods for transient delivery of nucleases
#162RSV F protein mutants
#163FMDV and E2 fusion proteins and uses thereof
#164NOVEL RECOMBINANT ADENO-ASSOCIATED VIRUS CAPSIDS CONTAINING A DESIGNED ANKYRIN REPEAT PROTEIN (DARPIN) OR FRAGMENT THEREOF
#165MULTIMERIC CONSTRUCTS
#166Multitarget-directed bio-inorganic hybrid structure
#167Virus-like particle with efficient epitope display
#168Nanocomposite matertail
#169Cell-directed synthesis of multifunctional nanopatterns and nanomaterials
#170Therapeutic cancer vaccine targeted to HAAH (aspartyl-[asparaginyl]-beta-hydroxylase
#171Theragnostic particles
#172Virus-like particle (VLP) based small molecule-protein interaction trap
#173Co-assembly peptides, nanostructures, and methods of making and using the same
#174Compositions and methods for transient delivery of nucleases
#175Polypeptide assemblies and methods for the production thereof
#176Recombinant self-assembling protein comprising target-oriented peptide and use thereof
#177Fusion proteins of natural human protein fragments to create orderly multimerized immunoglobulin Fc compositions
#178Expression and secretion system
#179Isolated nucleic acid encoding an anti-IGF-1R antibody
#180Programmable polypeptide and nucleic acid nanoparticles
#181Method for forming a reversible protein nanocluster using light in a cell
#182Chaperone-chaperone fusion polypeptides for reduction of interference and stabilization of immunoassays
#183T-cell redirecting bispecific antibodies for treatment of disease
#184Virus like particle comprising PD-1 antigen or PD-1 ligand antigen
#185Nucleic acid molecules encoding ferritin-hemagglutinin fusion proteins
#186Medical agents and uses thereof
#187RSV F protein mutants
#188FMDV and E2 fusion proteins and uses thereof
#189Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
#190GITRL fusion proteins comprising a human coronin 1a derived trimerization domain
#191T-cell redirecting bispecific antibodies for treatment of disease
#192Peptide capable of silica deposition and use thereof
#193Virion display array for profiling functions and interactions of human membrane proteins
#194Class of monospecific and bispecific humanized antibodies that target the insulin-like growth factor type I receptor (IGF-1R)
#195Baculovirus display vectors and uses thereof
#196Epstein-Barr virus vaccines
#197Self-assembling underwater adhesives
#198Influenza nucleoprotein vaccines
#199Designing a soluble full-length HIV-1 gp41 trimer
#200Methods and compositions for protein delivery
#201Rotavirus particles with chimeric surface proteins
#202Genetic reprogramming of bacterial biofilms
#203T-cell redirecting bispecific antibodies for treatment of disease
#204Chikungunya virus (CHIKV) or Venezuelan equine encephalitis virus (VEEV) virus-like particles comprising heterologous antigens inserted into the envelope protein
#205Prefusion RSV F proteins and their use
#206Self-assembling protein nanostructures
#207Theragnostic particles
#208Vaccines against HPV
#209Stabilized trimeric HIV-1 GP41 fusion inhibitor polypeptides comprising the N-terminal heptad repeat (NHR) and foldon (FD) trimerization motif
#210Method for forming a reversible protein nanocluster using light in a cell
#211Anti-HER2 vaccine based upon AAV derived multimeric structures
#212Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof
#213Methods of treating cancer with antibodies that target the insulin-like growth factor type I receptor (IGF-1R)
#214Self-Assembling Peptides Incorporating Modifications and Methods of Use Thereof
#215Trapping mammalian protein-protein complexes in virus-like particles utilizing HIV-1 GAG-bait fusion proteins
#216Disulfide stabilized foldon polypeptides
#217Cell-directed synthesis of multifunctional nanopatterns and nanomaterials
#218Protein constructs designed for targeting and lysis of cells
#219Spider silk fusion protein structures without repetitive fragment for binding to an organic target
#220Phage display using contranslational translocation of fusion polypeptides
#221Influenza hemagglutinin proteins and methods of use thereof
#222VACCINES AGAINST HPV
#223Method and kit for analyzing protein-protein interaction using nanocluster formation
#224Mutated and bacteriophage T4 nanoparticle arrayed F1-V immunogens from as next generation plague vaccines
#225Virus like particle comprising PD-1 antigen or PD-1 ligand antigen
#226Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof
#227Self-assembling peptides incorporating modifications and methods of use thereof
#228Use of GK-1 peptide expressed on M13 filamentous phage as pharmaceutical ingredient to enhance the efficiency of the immune response induced by vaccine or pathogen antigens
#229Therapeutic cancer vaccine targeted to HAAH (aspartyl-[asparaginyl]-β-hydroxylase)
#230IL-33 antagonists and uses thereof
#231Peptide capable of silica deposition and use thereof
#232Multimeric constructs
#233Means and methods for mediating protein interference
#234Designing a soluble full-length HIV-1 gp41 trimer
#235Biodegradable electroconducting nanowire, method of manufacture and uses thereof
#236Nucleic acid encoding a self-assembling split-fluorescent protein system
#237Infectious bronchitis virus (IBV) spike protein as subunit vaccine
#238Polypeptides and vectors for targeting HER2/expressing cells and uses thereof
#239Methods and compositions for heptameric targeting ligands
#240Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
#241Expression and secretion system
#242Virus like particle composition
#243Methods and compositions for treating HIV
#244TNF receptor Fc fusion proteins and in vivo methods of use
#245RECOMBINANT FLUORESCENT NANOPARTICLES
#246B-cell stimulating fusion proteins of an antigen with BAFF or APRIL
#247BACTERIOPHAGES EXPRESSING AMYLOID PEPTIDES AND USES THEREOF
#248Peptide amphiphiles and methods to electrostatically control bioactivity of the ikvav peptide epitope
#249BIO-NANO-PLASMONIC ELEMENTS AND PLATFORMS
#250VIRUS LIKE PARTICLES COMPRISING TARGET PROTEINS FUSED TO PLANT VIRAL COAT PROTEINS
#251MIMOTOPES OF HIV AND USES THEREOF
#252METHODS FOR PRODUCING MEMBERS OF SPECIFIC BINDING PAIRS
#253Means and methods for mediating protein interference
#254MULTIVALENT, DRYING RESISTANT, EVOLUTION-BASED VACCINES
#255Self-assembling peptides incorporating modifications and methods of use thereof
#256PROTEIN PARTICLES
#257Defense peptides against fungal infection and method of their use
#258PROTEASE RESISTANT MUTANTS OF STROMAL CELL DERIVED FACTOR-1 IN THE REPAIR OF TISSUE DAMAGE
#259Multimeric constructs
#260Nucleic acid encoding a self-assembling split-fluorescent protein system
#261Fusion Protein Delivery System and Uses Thereof
#262Methods and compositions for protein delivery
#263Fusion proteins and use thereof for preparing hepatitis C vaccines
#264Phage display using cotranslational translocation of fusion polypeptides
#265Soluble recombinant influenza antigens
#266MALVA MOSAIC VIRUS AND VIRUS-LIKE PARTICLES AND USES THEREOF
#267Phage lambda display constructs
#268ADAPTER MOLECULE FOR THE DELIVERY OF ADENOVIRUS VECTORS
#269Cell permeable peptide
#270MULTIMERIC PROTEINS ABLE TO INDUCE AN ANTIBODY RESPONSE AGAINST THE BETA-AMYLOID AND USE THEREOF
#271HIV COMBINATION VACCINE AND PRIME BOOST
#272CHIMERIC VARICELLA ZOSTER VIRUS VIRUS-LIKE PARTICLES
#273Baculoviruses with enhanced virion production and a method for the production of baculoviruses
#274BIOMATERIALS, COMPOSITIONS, AND METHODS
#275METHODS AND SUBSTANCES FOR THE TREATMENT OF ALZHEIMER'S
#276METHODS FOR PRODUCING MEMBERS OF SPECIFIC BINDING PAIRS
#277METHOD FOR SCREENING AN INHIBITORY AGENT OF HBV PROLIFERATION BY USING THE INTERACTION BETWEEN HBV CAPSID AND SURFACE PROTEINS BASED ON CELLULAR IMAGING
#278PAPAYA MOSAIC VIRUS-BASED VACCINES AGAINST SALMONELLA TYPHI AND OTHER ENTEROBACTERIAL PATHOGENS
#279Self-assembling peptide incorporating modifications and methods of use thereof
#280Immunogenic peptides of influenza virus
#281NASAL-ADMINISTERED VACCINES USING MULTI-SCREENED NALT-TARGETING AND PHAGOCYTIC POLYPEPTIDE TRANSPORT SEQUENCES
#282METHOD FOR SELECTING A PEPTIDE OR POLYPEPTIDE WHICH BINDS TO A TARGET
#283Novel Class of Monospecific and Bispecific Humanized Antibodies that Target the Insulin-like Growth Factor Type I Receptor (IGF-1R)
#284PLANT-PRODUCED COMPOSITIONS FOR TREATING PAPILLOMAVIRUS INFECTION AND RELATED METHODS
#285Viral polyhedra complexes and methods of use
#286Stabilized trimeric HIV-1 gp41 fusion polypeptides comprising the N-terminal heptad repeat (NHR) and foldon (FD) trimerization motif
#287Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
#288FUNCTIONALIZED MOLECULES COMPRISING AN AUTOSILIFICATION MOIETY AND METHODS OF MAKING AND USING SAME
#289METHODS FOR PRODUCING MEMBERS OF SPECIFIC BINDING PAIRS
#290TARGETED BIOCIDES
#291Combined human papillomavirus VLP/gene delivery system and use thereof as a vaccine for prophylaxis and immunotherapy of infectious diseases and tumors
#292Chimeric influenza virus-like particles
#293MULTIMERISED HIV FUSION INHIBITORS
#294CHIMERIC VIRUS-LIKE PARTICLES
#295ENRICHMENT METHOD FOR VARIANT PROTEINS WITH ALTERED BINDING PROPERTIES
#296VLP based vaccine delivery system
#297PRODUCTION OF ANTI-SELF ANTIBODIES FROM ANTIBODY SEGMENT REPERTOIRES AND DISPLAYED ON PHAGE
#298CHIMERIC VACCINE ANTIGENS AGAINST THE AVIAN INFLUENZA VIRUS
#299FILAMENTOUS BACTERIOPHAGE DISPLAYING PROTEIN AS A BINDER OF ANTIBODIES AND IMMUNOCOMPLEXES FOR DELIVERY TO THE BRAIN
#300VECTOR FOR SCREENING ANTIBODY